How Pharma Tech Industries turned its first major technology transfer into a blueprint for pharmaceutical manufacturing success
Seizing a Transformative Opportunity for Pharma Contract Manufacturing Companies
When Johnson & Johnson (J&J) decided to outsource some of its consumer products, Pharma Tech Industries was one of several pharma CDMO companies interested in the opportunity.
Challenges in Handling Large-Scale Pharma Manufacturing & Production
Pharma Tech Industries soon realized that to manufacture J&J’s products at a high standard required “outside the box” thinking. The problem was that in 2005, no one had the capacity to handle the enormous volume of topical powder products that J&J was then producing at its pharmaceutical manufacturing facility in Royston, Georgia.
Pharma Tech Industries’ Pharmaceutical Contract Manufacturing Solution
A full analysis by Pharma Tech Industries’ leadership showed that the fundamental step to set the stage for success was to acquire the entire 260,000-sq.-ft. pharma manufacturing facility. After being selected through a competitive bidding process, Pharma Tech Industries was awarded a long-term supply agreement. It improved the site’s operating capabilities, built a new ERP system from the ground up, and implemented other key innovations which transformed the operation from an in-house facility for J&J to a world leader in the external manufacturing and packaging of powder products.
Outcome: A Blueprint for Future CDMO Pharma Success
This defining moment in Pharma Tech Industries’ history was a site transfer - a highly successful one with many vital benefits: